Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/27758
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBöger, S-
dc.contributor.authorvan Bergen, I-
dc.contributor.authorBeaudart, C-
dc.contributor.authorCheung, KL-
dc.contributor.authorHiligsmann, M-
dc.date.accessioned2023-11-28T18:18:41Z-
dc.date.available2023-11-28T18:18:41Z-
dc.date.issued2023-06-14-
dc.identifierORCID iD: Charlotte Beaudart https://orcid.org/0000-0002-0827-5303-
dc.identifierORCID iD: Kei Long Cheung https://orcid.org/0000-0001-7648-4556-
dc.identifierORCID iD: Mickaël Hiligsmann https://orcid.org/0000-0003-4274-9258-
dc.identifier.citationBöger, S. et al. (2023) 'Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment', Expert Review of Pharmacoeconomics and Outcomes Research, 23 (8), pp. 921 - 931. doi: 10.1080/14737167.2023.2223983.en_US
dc.identifier.issn1473-7167-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/27758-
dc.descriptionAvailability of materials: Available under request to the corresponding author.en_US
dc.descriptionSupplemental material is available online at: https://www.tandfonline.com/doi/full/10.1080/14737167.2023.2223983#supplemental-material-section .-
dc.description.abstractCopyright © 2023 The Author(s).2023. Objectives: To determine preferences for COVID-19 vaccinations in the young adult population in the United Kingdom (UK). Method: A discrete choice experiment survey was conducted in UK young adults. Participants were asked to choose between two hypothetical vaccines the one they preferred the most. Vaccines were defined by five attributes (effectiveness, risk of side effects, duration of protection, number of doses, confidence in available evidence), identified following a systematic literature review and qualitative interviews with 13 young adults. A random parameters logit model, a latent class model, and subgroup analyses were used to identify preferences. Results: One hundred and forty-nine respondents were included (70% women, mean age 23 years). All five attributes significantly influenced respondents’ vaccination decisions. Respondents valued higher effectiveness, lower risk of side effects, longer protection duration, and a smaller number of doses. Based on the range of levels of each attribute, vaccine effectiveness was the most important attribute (relative importance 34%), followed by risk of side effects (32%), and duration of vaccine protection (22%). Conclusions: The five investigated vaccine attributes appear to play an important role in young adults’ decision-making process. Results of this study may help health authorities designing appropriate strategies in future vaccines campaigns in the younger UK population.en_US
dc.description.sponsorshipThis paper was not funded.en_US
dc.format.extent921 - 931-
dc.format.mediumPrint-Electronic-
dc.languageEnglish-
dc.language.isoenen_US
dc.publisherRoutledge (Taylor & Francis Group)en_US
dc.rightsCopyright © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectCOVID-19en_US
dc.subjectpreferenceen_US
dc.subjectvaccineen_US
dc.subjecthealth policyen_US
dc.subjectdiscrete choice experimenten_US
dc.titlePreference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experimenten_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1080/14737167.2023.2223983-
dc.relation.isPartOfExpert Review of Pharmacoeconomics and Outcomes Research-
pubs.issue8-
pubs.publication-statusPublished-
pubs.volume23-
dc.identifier.eissn1744-8379-
dc.rights.holderThe Author(s)-
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.1.5 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons